Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Cabaletta Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get CABA alerts

About Scott Brun, M.D.

Scott Brun, M.D. is recorded as Board Member at Cabaletta Bio, Inc. (CABA) since June 1, 2023. Cabaletta Bio, Inc. reported in an 8-K filed July 24, 2023 that Scott Brun, M.D. was appointed Chair of the NCG Committee, effective July 21, 2023. Cabaletta Bio, Inc. reported in an 8-K filed June 1, 2023 that Scott Brun, M.D. was appointed Class I director, effective June 1, 2023. Cabaletta Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cabaletta Bio, Inc. includes Steven Nichtberger (CEO and Board Member), Anup Marda (CFO), Michael Gerard (General Counsel) and 3 others.

“(iii) Scott Brun, M.D. was appointed as the new Chair of the NCG Committee.”
Cabaletta Bio, Inc. Form 8-K, filed July 24, 2023 · Read the filing
“The Company's stockholders approved the Class I director nominee, Scott Brun, M.D., recommended for election in Proposal 1 at the Annual Meeting.”
Cabaletta Bio, Inc. Form 8-K, filed June 1, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Cabaletta Bio, Inc.

Recent activity